Skip to main content
. 2024 Jun 23;63:38886. doi: 10.2340/1651-226X.2024.38886

Figure 4.

Figure 4

Progression-free survival by: (A) ER-receptor-status, (B) disease presentation, (C) age, and (D) (neo)adjuvant chemotherapy.

mPFS: median progression free survival; CI: confidence interval; ER: estrogen receptor; rBC: recurrent breast cancer